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The diagnosis of pseudohypoparathyroidism type 1a (PHP1a) is challenging, because both the osteodystrophy, such as
brachydactyly and round face, and the symptomatic hypocalcemia usually develop beyond infancy. Although ectopic calciﬁcation
may be an early sign of PHP1a, there are no systematic reviews regarding the time of its appearance. We here report on two PHP1a
patients who presented with subcutaneous calciﬁcation in neonatal period.
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1.Introduction
Pseudohypoparathyroidism type 1a (PHP1a) is a genetic
disorder caused by maternally inherited mutations of GNAS
gene, which encodes the α-subunit of the stimulatory G pro-
tein Gs [1, 2]. Common feature in PHP1a includes Albright
hereditary osteodystrophy (AHO) such as brachydactyly [3]
and resistance to multiple Gs protein-coupled hormones
(e.g., parathyroid hormone (PTH) and thyrotropin) [1].
Individuals with GNAS mutation on paternally inherited
alleles manifest only AHO, a variant termed pseudopseu-
dohypoparathyroidism (pseudo-PHP) [4]. The diagnosis of
PHP1a often delays due to the high variability of the age
at ﬁrst appearance of characteristic clinical signs [5]. Here
we report on two PHP1a patients with GNAS mutations,
who were found to have subcutaneous calciﬁcation during
neonatal period.
2. Patient 1
A male baby was born to nonconsanguineous Japanese
parents after an uneventful pregnant course. He was deliv-
ered by Caesarian section because of bradytocia at his
36 weeks of gestation with his weight measuring 2545g.
Asphyxia was absent. At his 3 days of age, he developed
vomiting and hypothermia and was found to have hypocal-
cemia (5.6mg/dL). With parenteral infusion of calcium
preparation, the above symptoms resolved soon. Calcium
supplementation could be withdrawn in a month. By 13 days
of age, a subcutaneous nodule at right parietal region was
noticed, which was thought to be an ectopic calciﬁcation
by skull radiograph (Figure 1). Intracranial calciﬁcations,
particularly those in basal ganglia, were not found by CT
scanning. Despite normocalcemia, his plasma level of intact
PTHhadbeenelevatedcontinuously(55–460pg/mL),which
raised the tentative diagnosis of PHP1a. Deﬁnite diagnosis,
however, was withheld because AHO phenotype was not
evident at that time except for ectopic calciﬁcation. Because
of hypothyroidism, thyroid hormone supplementation was
initiated at his 1 year of age. Clinical reevaluation at 4 years
of age revealed BMI of 26.8 (above 97th centile, according
to the Japanese national survey data [6]), brachydactyly, and
r o u n df a c e .H i sc a l c i u ml e v e lw a ss t i l ln o r m a l( 9 . 0m g / d L ) .
GNAS gene analysis, under the approval of institutional
reviewboardandwritteninformedconsentfromtheparents,
revealed the recurrent mutation [7] of 565-568delGACT2 International Journal of Endocrinology
Figure 1: Skull radiograph of patient 1 taken on 13 days of age.
White arrow indicates the calciﬁcation at right parietal region.
R
Figure 2: Skull CT image of patient 2 taken at 7 months of age.
Calciﬁcation at right parietal region is evident.
(189Dfr) in heterozygous state. His mother had short stature
of 145cm (−2.5SD for Japanese women) and brachydactyly,
which led to the presumed diagnosis of pseudo-PHP. She,
however, did not request DNA analysis.
3. Patient 2
Patient 2 is a Japanese boy who was born at 36 weeks
of gestation by Caesarian section with his weight 2892g.
His elderly brother has ceased at day 1 because of enteric
necrosis of unknown origin. His mother had been treated
for threatened abortion by magnesium preparation for a
month before delivery. Although asphyxia was absent, he
developed respiratory distress and hypoglycemia soon after
birth, both of which subsided spontaneously. At 2 days
of age, hypocalcemia of ionized calcium of 0.81mmol/L
was noticed, which warranted calcium supplementation for
about a month. From 9 days of age, he was treated for
hypothyroidism. Around 2 weeks of age, a subcutaneous
hard nodule was recognized at the right parietal region, CT
scanning of which revealed it to be an ectopic calciﬁcation
(Figure 2). At 6 months of age, brachydactyly and round
face were noticed, which raised the suspicion of PHP1a. In
addition, several hard nodules less than 10mm in diameters
were present in his back and thigh, which seemed sub-
cutaneous calciﬁcations. Although hypocalcemia had been
absent, his PTH level was found to be high (134pg/mL) after
1.5 year of age. His developmental quotient determined at
his 1.5 years of age was 70. GNAS analysis of the family
was performed under the approval of institutional review
board and written informed consent from the parents. The
patient and his mother, who is 140cm tall (−3.4SD), had
heterozygous nonsense mutation (W261X), whereas GNAS
of his father, who is 160cm tall (−1.9SD), was wild type.
4. Discussion
Duringinfantileperiod,theclinicalmanifestationsofPHP1a
areusuallysubtleand,therefore,tendtobeeasilyoverlooked.
I nac a s es e r i e ss t u d y ,G e l f a n de ta l .[ 5] reported that
brachydactylyinPHP1awasrarelynotedintheﬁrst3yearsof
life, although it was eventually recognized in all 12 patients.
In addition, they found that symptomatic hypocalcemia
developed later in childhood and that none required calcium
and/or calcitriol administration in the ﬁrst year of life [5].
Subcutaneous calciﬁcations and/or ossiﬁcations have
also been considered to be one of the constituents of AHO
[3]. In a recent study [7], the average of heterotopic ossiﬁ-
cations in 12 patients with PHP1a who attended orthopedic
clinic was reported to be 10 in number, and no speciﬁc ten-
dency was observed regarding the location of ossiﬁcations.
Gelfand et al. [5] found that ectopic calciﬁcations, next to
hypothyroidism, were the second most referral reason in
infants with PHP1a. However, detailed evaluation regarding
the onset of ectopic calciﬁcations has not been made, and the
early onset of ectopic calciﬁcations with AHO has been only
anecdotally described [8, 9].
In our patients, subcutaneous calciﬁcations were noticed
no later than 2 weeks of age, and they might be already
present shortly after birth. As long as we could search
in literature, they may be the ﬁrst cases of molecularly
proven PHP1a who developed neonatal-onset subcutaneous
calciﬁcations. If this manifestation was paid more attention,
it might lead to earlier diagnosis, especially in patient
2. Thus, pediatricians and neonatologists should keep in
mind that ectopic calciﬁcations may be the early discernible
manifestation of PHP1a.
Subcutaneous calciﬁcations must be distinguished from
other conditions. Ectopic calciﬁcations are most frequently
reported after subcutaneous fat necrosis following extrava-
sation of calcium gluconate. It can be seen also in hyper-
parathyroidism, sarcoidosis, and dermatomyositis, and so
forth. In addition, paternally inherited GNAS mutation may
cause a rare disease termed progressive osseous heteroplasiaInternational Journal of Endocrinology 3
(POH)[7].SubcutaneousossiﬁcationsinPOHareaccompa-
nied with ossiﬁcations in cutaneous and in deep connective
tissues including muscle. Fibrodysplasia ossiﬁcans progres-
sive (FOP) is another condition manifesting heterotopic
ossiﬁcation [10]. Patients with FOP usually present with
congenital malformations of the great toes, and the average
age at onset of ossiﬁcation was reported to be 5 years [10].
In conclusion, it should be emphasized that ectopic cal-
ciﬁcations in neonates may indicate the systemic disorders.
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